anmelden
OMX Nordic 40
2.675,31
PKT
+57,36
PKT
+2,19
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 26.02.26 | AstraZeneca Buy | UBS AG | |
| 25.02.26 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 24.02.26 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 24.02.26 | Volvo (B) Market-Perform | Bernstein Research | |
| 24.02.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 24.02.26 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 24.02.26 | Hennes Mauritz (H M, H&M) Underweight | Barclays Capital | |
| 24.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 24.02.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 23.02.26 | Novo Nordisk Hold | Deutsche Bank AG | |
| 23.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 23.02.26 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 23.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 23.02.26 | Novo Nordisk Neutral | UBS AG | |
| 23.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 23.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 23.02.26 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 19.02.26 | Volvo (B) Hold | Deutsche Bank AG | |
| 19.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 18.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 18.02.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 16.02.26 | Volvo (B) Buy | UBS AG | |
| 16.02.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 13.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 13.02.26 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 13.02.26 | AstraZeneca Outperform | Bernstein Research | |
| 13.02.26 | Hennes Mauritz (H M, H&M) Underweight | Barclays Capital | |
| 12.02.26 | AstraZeneca Halten | DZ BANK | |
| 12.02.26 | Volvo (B) Buy | UBS AG | |
| 12.02.26 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.02.26 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 11.02.26 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 11.02.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 11.02.26 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.02.26 | AstraZeneca Overweight | Barclays Capital | |
| 10.02.26 | AstraZeneca Buy | UBS AG | |
| 10.02.26 | AstraZeneca Overweight | Barclays Capital | |
| 10.02.26 | AstraZeneca Buy | Jefferies & Company Inc. |